Form D — Can-Fite BioPharma Ltd.

0001213900-26-098844 · filed Sep 10, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Reported offering amount: $8,306,884
Reported amount sold: $8,306,884
Minimum investment: $0
Investors: 1
Sales commission: $278,554
Finders' fees: $0

Issuer

Name: Can-Fite BioPharma Ltd.
CIK: 1536196
Entity: Corporation
Jurisdiction: ISRAEL
Year incorporated: —
Address: 26 BEN GURION STREET
RAMAT GAN, L3 5257346
Phone: +972 (3) 924-1114

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Motti Farbstein · Executive Officer

Ramat Gan, L3 Find on LinkedIn ↗
Pnina Fishman · Executive Officer

Ramat Gan, L3 Find on LinkedIn ↗
Sari Fishman · Executive Officer

Ramat Gan, L3 Find on LinkedIn ↗
Guy Regev · Director

Ramat Gan, L3 Find on LinkedIn ↗
Abraham Sartani · Director

Ramat Gan, L3 Find on LinkedIn ↗
Yoseph Bornstein · Director

Ramat Gan, L3 Find on LinkedIn ↗
Ilan Tamir · Director

Ramat Gan, L3 Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗